Novel compounds

Details for Australian Patent Application No. 2001292619 (hide)

Owner SmithKline Beecham Corporation Glaxo Group Limited SmithKline Beecham P.L.C.

Inventors Agarwal, Pankaj; Xie, Qing; Smith, Randall F.; Lai, Ying-Ta; Strum, Jay C.; Martensen, Shelby A.; Gogswell, John P.

Agent Davies Collison Cave

Pub. Number AU-B-2001292619

PCT Pub. Number WO02/22802

Priority 60237293 02.10.00 US; 60232463 13.09.00 US; 60246269 07.11.00 US; 60252049 20.11.00 US; 60232455 13.09.00 US

Filing date 13 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 12 January 2006

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

12 January 2006 Application Accepted

  Published as AU-B-2001292619

11 May 2006 Standard Patent Sealed

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292620-Bioluminescent bioreporter integrated circuit detection methods

2001292618-Methods and products related to low molecular weight heparin